Home Newsfeeds Morgan Stanley Initiates Coverage On STMicroelectronics with Equal-Weight Rating

Morgan Stanley Initiates Coverage On STMicroelectronics with Equal-Weight Rating

Morgan Stanley analyst Lee Simpson initiates coverage on STMicroelectronics (NYSE:STM) with a Equal-Weight rating.

byBenzinga Newsdesk

November 8, 2022

1 minute read

Morgan Stanley analyst Lee Simpson initiates coverage on STMicroelectronics (NYSE:STM) with a Equal-Weight rating.

News
Tech

Apple Hits Pause On iOS18, Other Software Developments To Address Bugs

By Benzinga Neuro

November 7, 10:32 PM

In a move that underscores the tech giant’s commitment to software quality, Apple Inc. (NASDAQ:AAPL) has reportedly decided…

AAPL

Analyst Ratings

17 Analysts Have This to Say About Accenture

By Benzinga Insights

September 8, 3:00 PM

Analysts have provided the following ratings for Accenture (NYSE:ACN) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

ACN

Vuzix Receives OEM Order From Client Enabling Imaging Technology Solutions For Government, Defense And Commercial Markets; No Financial Terms Disclosed

By Happy Mohamed

July 10, 8:46 AM

Vuzix® Corporation (NASDAQ:VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, is pleased to announce the receipt

VUZI

Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares

By Lara Goldstein

October 3, 10:56 AM

NY Mets owner billionaire Steve Cohen has bought as many as 119,092,680 ordinary shares of clinical-stage biopharmaceutical company Bionomics Limited (NASDAQ: BNOX) through his Point72 asset management firm, again showing support for the biopharma sector.

BNOX

Morgan Stanley Initiates Coverage On STMicroelectronics with Equal-Weight Rating

Related Posts

Apple Hits Pause On iOS18, Other Software Developments To Address Bugs

17 Analysts Have This to Say About Accenture

Vuzix Receives OEM Order From Client Enabling Imaging Technology Solutions For Government, Defense And Commercial Markets; No Financial Terms Disclosed

Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares